n.a. (CYBX)

pos +0.86
Today's Range: 68.66 - 70.25 | CYBX Avg Daily Volume: 0
Last Update: 10/16/15 - 4:00 PM EDT
Volume: 4,082,242
YTD Performance: 0.00%
Open: $69.12
Previous Close: $69.09
52 Week Range: $48.19 - $76.48
Oustanding Shares: 0
Market Cap: 0
6-Month Chart
TheStreet Ratings Grade for CYBX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy
Moderate Buy
Moderate Sell
Strong Sell
Mean Rec. 0.00 0.00 0.00 0.00
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
CYBX Sector Avg. S&P 500
0.00 0.00 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
Revenue 0.00 0.00 0.00
Net Income 0.00 0.00 0.00
EPS 0.00 0.00 0.00
Earnings for CYBX:
Revenue 0.00B
Average Earnings Estimates

Earnings Estimates data is not available for CYBX.

Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands

Ed Ponsi

 | Aug 28, 2015 | 2:30 PM EDT

Let's review.


Timothy Collins

 | Aug 27, 2015 | 9:57 AM EDT

With a pending merger pushing the stock, the technical picture still looks strong.


James "Rev Shark" DePorre

 | Jun 11, 2015 | 4:36 PM EDT

And the market deserves a positive bias.

bearishCyberonics downgraded at Jefferies

Mar 6, 2015 | 7:57 AM EST

CYBX was downgraded to Hold, Jefferies said. $75 price target. Valuation call, given the prospects of the Sorin merger. 


Jim Cramer

 | Feb 26, 2015 | 2:31 PM EST

But there's just too much good news.

bearishCyberonics downgraded at Sterne Agee

Nov 21, 2014 | 7:34 AM EST

CYBX was downgraded to Neutral, Sterne Agee said. Domestic sales have stalled and growth headwinds remain. 

bearishCyberonics downgraded at Canaccord

Aug 22, 2014 | 7:12 AM EDT

CYBX was downgraded from Buy to Hold, Canaccord Genuity said. $52 price target. New U.S. patient growth is slowing. 

bullishCyberonics price target and estimates raised at Lazard

Jun 6, 2013 | 8:34 AM EDT

CYBX earnings estimates were increased on raised guidance as strength is seen across the U.S. and Europe, Lazard Capital. Price target increased to $57.

bullishCyberonics upgraded at Lazard

Mar 4, 2013 | 7:22 AM EST

CYBX was upgraded to Buy, Lazard Capital Market said. A proprietary survey showed that sales reps were not using inappropriate sales tactics, making the recent pullback a buying opportunity. Estimates through 2014 were raised, $57 price target. 

bullishCyberonics numbers raised at Canaccord

Nov 19, 2012 | 8:43 AM EST

Shares of CYBX now seen reaching $57, Canaccord said. Estimates also raised on a record quarter. Buy rating.

We will take off some more risk, bank some winners SOLD PG OCT 90 CALL AT...
After a very calm and sedate period of volatility which saw the VIX fall not only to all t...
today is a good day to lighten the load and take some positions off the table. SOLD WB ...


News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.